Report - Yohann Loriot - BiennaleCancerologieIMvigor 210, a Phase II trial of Atezolizumab (MPDL3280A) in Platinum-treated Locally Advanced or Metastatic Urothelial Carcinoma (mUC) Jean Hoffman-Censits,1

Please pass captcha verification before submit form